COMMUNIQUÉS West-GlobeNewswire

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

25/04/2025 - 18:36

Discover the best SARMs for bulking, cutting, fat loss, and muscle growth in 2025. Boost strength, shred fat, and enhance performance naturally with powerful, legal SARMs alternatives. New York City, April 25, 2025 ( [...]

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

25/04/2025 - 19:00

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, announced today the [...]

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

25/04/2025 - 19:00

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF [...]

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

25/04/2025 - 19:00

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory [...]

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

25/04/2025 - 19:00

Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech ( [...]

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

25/04/2025 - 19:00

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 [...]

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

25/04/2025 - 19:00

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep [...]

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

25/04/2025 - 19:00

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value [...]

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

25/04/2025 - 19:00

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 [...]

Avis aux médias - Exposition Réalité Virtuelle 2025 : Accélérer l'innovation en matière de soins de santé

25/04/2025 - 13:30

MONTRÉAL, 25 avr. 2025 (GLOBE NEWSWIRE) -- Les représentants des médias sont cordialement invités à l’édition 2025 de la RV Expo : accélérer l’innovation en matière de soins de santé, un événement immersif qui explore [...]

Media Advisory - 2025 Virtual Reality Expo: Accelerating Innovation in Healthcare

25/04/2025 - 13:30

MONTREAL, April 25, 2025 (GLOBE NEWSWIRE) -- Media representatives are invited to the 2025 edition of the VR Expo: Accelerating Innovation in Health Care , an immersive event that explores the potential of virtual [...]

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

25/04/2025 - 13:35

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

25/04/2025 - 13:37

Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, [...]

Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ

25/04/2025 - 13:37

Curb cravings and support effective hunger control with the best over-the-counter appetite suppression pills of 2025. Discover natural OTC solutions designed to boost energy, reduce snacking, and enhance portion control [...]

Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!

25/04/2025 - 13:39

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- Flush Factor Plus is a natural dietary supplement that claims to support fluid retention and promote joint mobility and flexibility. Knee pain and joint issues due to improper [...]

Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma

25/04/2025 - 13:43

SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]

BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes

25/04/2025 - 13:45

April 25, 2025 Announcement no. 12 BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes Completion of share capital increase COPENHAGEN, DENMARK, April 25, 2025 (GLOBE [...]

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

25/04/2025 - 13:55

Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Managers’ transactions

25/04/2025 - 13:55

April 25, 2025 Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 12, BioPorto A/S has received notification pursuant to [...]